Inside Pear’s ambitious plan to become the most dominant player in digital therapeutics
The company already has three FDA authorized therapeutics on the market, a dozen products in its pipeline, and new technologies in the works.
Read The StoryHealth Tech
Tracking how tech is transforming health care and the life sciences. To get the latest delivered to your inbox, sign up for our free STAT Health Tech newsletter. And subscribe to STAT+ for exclusive analysis of the interlopers and technologies disrupting health care.
All Coverage
advertisement
